First U.S. patients treated with Aorfix flexible aortic stent graft

Lombard Medical Technologies PLC, has announced that the first U.S. patients have been successfully treated with Aorfix™, the Group's flexible stent graft for the endovascular repair of abdominal aortic aneurysms (AAAs). Aorfix was approved by the FDA for commercial sale in the U.S. in February 2013. The approval included a label indication for the treatment of patients with angulations at the neck of the aneurysm from 0 to 90 degrees...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news